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monocytic cells
Abstract
Porphyromonas gingivalis is a major bacterial species implicated in chornic periodontitis, a disease
characterized by inflammatory destruction of the tooth supporting tissues. Its main virulence factors are
lipopolysaccharide (LPS) and gingipains, a group of cysteine proteinases. Interleukin (IL)-18 is a potent
pro-inflammatory cytokine with structural similarities to IL-1beta. This study aimed to investigate if P
.gingivalis regulates IL-1beta and IL-18 in monocytic cells. Monomac-6 cells were challenged with P.
gingivalis culture supernatants. Quantitative real-time PCR and ELISA were used to investigate
IL-1beta and IL-18 mRNA expression and protein secretion, respectively. P. gingivalis enhanced
IL-1beta and IL-18 mRNA expression, the former being induced earlier, but transiently. IL-18
up-regulation was not affected by P. gingivalis heat-inactivation or chemical inhibition of its gingipains,
whereas both treatments resulted in 50% reduction of IL-1beta expression. Purified P. gingivalis LPS
enhanced both IL-1beta and IL-18 expression. However, only IL-1beta, but not IL-18, secretion was
detected, and was up-regulated by P. gingivalis. In conclusion, although IL-1beta and IL-18 belong to
the same cytokine family, their gene expression and secretion are differentially regulated in human
monocytic cells in response to P. gingivalis. Therefore, cytokines of the IL-1 family may participate via
different pathways in the complex pathogenesis of periodontitis.
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Abstract 
Porphyromonas gingivalis is a major bacterial species implicated in chornic 
periodontitis, a disease characterised by inflammatory destruction of the tooth 
supporting tissues. Its main virulence factors are lipopolysaccharide (LPS) and 
gingipains, a group of cysteine proteinases. Interleukin (IL)-18 is a potent pro-
inflammatory cytokine with structural similarities to IL-1β. This study aimed to 
investigate if P .gingivalis regulates IL-1β and IL-18 in monocytic cells. Monomac-6 
cells were challenged with P. gingivalis culture supernatants. Quantitative real-time 
PCR and ELISA were used to investigate IL-1β and IL-18 mRNA expression and 
protein secretion, respectively. P. gingivalis enhanced IL-1β and IL-18 mRNA 
expression, the former being induced earlier, but transiently. IL-18 up-regulation was 
not affected by P. gingivalis heat-inactivation or chemical inhibition of its gingipains, 
whereas both treatments resulted in 50% reduction of IL-1β expression. Purified P. 
gingivalis LPS enhanced both IL-1β and IL-18 expression. However, only IL-1β, but 
not IL-18, secretion was detected, and was up-regulated by P. gingivalis. In 
conclusion, although IL-1β and IL-18 belong to the same cytokine family, their gene 
expression and secretion are differentially regulated in human monocytic cells in 
response to P. gingivalis. Therefore, cytokines of the IL-1 family may participate via 
different pathways in the complex pathogenesis of periodontitis. 
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1. Introduction 
Periodontal diseases are multi-factorial infectious diseases that manifest clinically by 
destruction of the tooth-supporting tissues. More than 700 species can colonize the 
oral cavity [1, 2] and approximately 500 species may be detected in subgingival 
bacterial biofilms [3]. However, there is evidence that only a few of these species are 
involved in the initiation and progression of periodontal disease [4]. Porphyromonas 
gingivalis is a gram-negative black-pigmenting anaerobe, reported to be a major 
component of the pathogenic microbiota in periodontal diseases [4-7]. P. gingivalis 
challenge elicits signals in host cells, especially monocytes, via its lipopolysaccharide 
(LPS) [8] and Arg- and Lys-X cysteine proteinases, or gingipains [9]. The responses 
to these signals are perturbation of local immunity and deregulation of the host’s 
normal inflammatory processes, to the advantage of the invading pathogen [10]. 
The pathogenesis of periodontal disease is largely attributed to localized 
inflammation, which results from interactions between host and microbial factors [11-
13]. In this respect, pro-inflammatory and regulatory cytokines in the inflamed 
periodontal tissues are key elements in periodontal disease progression. Inflammatory 
cytokines of the Interleukin(IL)-1 family are present in the diseased periodontal 
tissues, and their excessive production is considered detrimental for tissue destruction 
[14, 15]. 
Interleukin-18 is a potent pro-inflammatory cytokine belonging to the IL-1 
cytokine family, with structural similarities to IL-1β [16]. Despite this, the regulation 
of IL-18 gene expression, synthesis, processing, and secretion appear to be distinct to 
that of IL-1β. It is synthesized as a 24-kDa biologically inactive precursor protein [17] 
that is stored intracellularly, and becomes active and secreted after cleavage by IL-1β-
converting enzyme (ICE), or proteinase-3 [18-20]. IL-18 is produced by a variety of 
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cell types including monocytes, dendritic cells, epithelial cells, keratinocytes [21]. It 
is shown to amplify the inflammatory response by promoting the release of other 
cytokines, in particular tumor necrosis factor (TNF)-α and interferon (IFN)-γ [22]. 
Several reports associate an up-regulation of IL-18 to human inflammatory and 
infectious diseases, including rheumatoid arthritis [23-25], sepsis [24] and 
periodontitis [26-28].  
Although there is a vast amount of data supporting the pivotal role for IL-1β in 
mediating the host response to periodontal pathogens and the associated tissue 
damage, only a few studies have addressed the involvement of IL-18 in this respect. 
In particular, oral epithelial cells and monocytes, but not gingival fibroblasts are 
shown to produce IL-18 in response to P. gingivalis LPS [29-31]. However, the 
effects of LPS alone may not be representative of the capacity of P. gingivalis to 
regulate IL-18, or other cytokines of the IL-1 family. This study aimed to a) 
investigate the effects of P. gingivalis on the regulation of IL-18 by a monocytic cell 
line, and compare these to the effects on IL-1β and, b) to identify the nature of P. 
gingivalis virulence factors potentially involved in these processes.  
 
2. Materials and Methods  
2.1 Cell cultures 
The human myelomonocytic cell line Monomac-6 was obtained from the German 
Collection of Microorganisms and Cell Cultures (Mascheroder, Braunschweig, 
Germany). MonoMac-6 cells were cultured in RPMI-Glutamax (Gibco BRL Life 
Technologies, UK) supplemented with 10% fetal bovine serum, 1% non-essential 
amino acids (Gibco BRL), 1% sodium pyruvate (Gibco BRL) and 9 µg/ml bovine 
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insulin (Sigma-Aldrich). Thereafter, Monomac-6 cells (1x106/ml) were cultured in 
presence or absence of P. gingivalis bacterial culture supernatants for up to 24 h.  
 
2.2 Bacteria and growth conditions 
The P. gingivalis W50 strain was cultured on blood agar base supplemented with 5% 
horse blood (Oxoid, Hampshire, UK) and maintained by weekly subculture for up to 5 
weeks. Liquid cultures were prepared by inoculation of bacterial colonies (3-4 days 
old) from blood agar plates into 10 ml brain heart infusion (BHI) broth (Oxoid, 
Hampshire, UK) supplemented with 5 mg/L hemin (Sigma, Dorset, UK), and 
incubated for 24 h. Ten percent inoculum was then transferred to 90 ml of the same 
medium and incubated for 6 days. All cultures were grown at 37°C in a Don Whitley 
anaerobic cabinet, MACS MG500, in an atmosphere of 80% N2, 10% H2, and 10% 
CO2. After this culture period, bacteria were harvested by centrifugation at 10,000 x g 
for 15 min at 4˚C and supernatants were collected, filter-sterilized over a 0.2 µm filter, 
and stored at -80˚C until use.  
 
2.3 Characterization of bacterial culture supernatants 
The preparations of P. gingivalis were diluted in the cell-culture medium, and their 
concentration is expressed as total bacterial protein (µg/ml) present in the cell 
cultures. Protein concentration was determined by Bio-Rad Protein assay (Bio-Rad, 
Hertfordshire, UK), and absorbances were determined spectrophotometrically at 
wavelengths of 595 nm. Arg-X protease activity was measured in 0.1 M Tris-HCl (10 
mM L-cysteine, 10 mM CaCl2, pH 8.1, 30°C) with N-benzoyl-DLarginine p-
nitroanilide (DL-BApNA) (500 mM) as the substrate. Lys-X protease activity was 
measured with N-α-acetyl-L-lysine-p-nitroanilide (AcLyspNA) (250 mM) as 
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substrate in the same reaction buffer, and under the same conditions as described 
above. The reactions were monitored at 405 nm, and enzyme activity was expressed 
in units. One unit of protease activity is defined as the amount of enzyme causing an 
increase in the absorbance of 1.0 min-1, at 30°C. The concentrations of LPS and the 
protease activities in the bacterial culture supernatants are reported elsewhere [32, 
33]. To investigate the involvement of P. gingivalis cysteine proteinases, or 
proteinaceous components in general, the culture supernatants were treated with the 
specific cysteine proteinase inhibitor TLCK (1mM) for 1 h at 4˚C, or heat-inactivated 
for 1 h at 70˚C, respectively. The treatment with TLCK resulted in reduction of the 
Arg-X and Lys-X activities by 91% and 90%, respectively [32], whereas heat-
treatment abolished both cysteine proteinase activities below detection levels. 
 
2.4 Preparation of LPS from P. gingivalis 
For LPS purification, P. gingivalis W50 was grown anaerobically in brain–heart 
infusion supplemented with haemin (5 µg/ ml) for 24 hours. The bacterial cells were 
harvested, washed with water and freeze-dried. P. gingivalis LPS was prepared by the 
cold MgCl2-ethanol procedure as described previously [34]. LPS was lyophilized to 
determine the yield and stock solutions were prepared in pyrogen-free distilled water 
(1 mg/ml) and vortexed prior to use. No protein was detected in LPS preparations. 
 
2.5 Cytotoxicity assay 
The putative cytotoxic effects of P. gingivalis on Monomac-6 cells were evaluated by 
measurement of the extracellularly released cytosolic lactate dehydrogenase (LDH), 
using the CytoTox96® Non-Radioactive Cytotoxicity Assay (Promega, Southampton, 
UK). In brief, triplicate cell cultures were exposed to ascending concentrations P. 
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gingivalis supernatant protein for up-to 24 h. Cell culture supernatants were thereafter 
collected, and the cell monolayer was lysed in equal volume of lysis buffer, provided 
in the kit. The collected suspensions, either cell-culture supernatant or cell lysate, 
were centrifuged at 1,000 rpm for 5 min to pellet down any cell debris, and thereafter 
100 µl/well of each were transferred into an optically clear 96-well plate. Reaction 
solution was added to each well and incubated for 30 min in the dark. This enzyme 
reaction was then stopped by the addition of 1N HCl. The absorbance was measured 
at 490 nm, and background values were subtracted from all samples.  
 
2.6 RNA extraction and cDNA synthesis 
For the investigation of IL-1β and IL-18 gene expression, the cell cultures were 
challenged with ascending concentrations of P. gingivalis culture supernatants for 
time-points up-to 24 h. Upon termination of these experiments, the cell culture media 
were discarded, and the cell monolayers were washed twice in PBS, and then were 
lysed with RLT buffer (provided in the RNA extraction kit). The collected cell lysate 
was homogenized with QIAshredder (QIAGEN, Crawley, UK), and total RNA was 
extracted by using the RNeasy Mini Kit (QIAGEN, Crawley, UK), according to the 
manufacturer’s instructions. The extracted RNA was finally eluted in 40 µl RNase 
free water and its concentration was measured in a NanoDrop spectrophotometer. One  
µg of total RNA was reverse transcribed into single-stranded cDNA by using M-MLV 
Reverse Transcriptase (RNase H Minus, Point Mutant), Oligo(dT)15 Primers, and 
PCR Nucleotide Mix according to the manufacturer’s protocol (all from Promega, 
Southampton, UK), at 40°C for 60 min, and 70°C for 15 min. The resulting cDNA 
was stored at -20°C until further use. 
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2.7 Quantitative real-time PCR 
For IL-1B and IL-18 gene expression analysis, quantitative TaqMan® real-time PCR 
was performed in an ABI Prism 7900HT Sequence Detection System and software 
(Applied Biosystems, Foster City, CA). The probes and the primers in the Gene 
Expression Assays were by Applied Biosystems. The assay IDs were IL-18: 
Hs01038787, IL1B: Hs00174097, GAPDH: Hs99999905, and Ubiquitin C (UBC): 
Hs01871556. The amplification reactions were performed with a qPCR Master Mix 
(Abgene, Epsom, UK). The standard PCR conditions were 10 min at 95ºC, followed 
40 cycles at 95ºC for 15 seconds and 60ºC for 1 min. The expression levels of IL-18 
and IL-1B transcripts were calculated by using the comparative Ct method (2-∆Ct 
formula) after normalization to house-keeping genes. GAPDH and UBC were used as 
house-keeping genes, and their average Ct was used to normalise the Ct values of the 
target genes. 
 
2.8 Determination of IL-1β and IL-18 secretion levels 
Secreted cytokine levels were determined in the collected cell-free culture 
supernatants, by means of commercially available ELISA kits (Human IL-1β DuoSet, 
R&D Systems, Minneapolis, MN. Human IL-18 ELISA kit, MBL International, 
Woburn, MA, and Human IL-18 Instant ELISA Bender MedSystems, UK). The assay 
sensitivities for the three kits were 1.9 pg/ml, 15.6 pg/ml, and 78 pg/ml, respectively. 
The absorbance at 450 nm was read using a microplate reader (FluoStar OPTIMA, 
BMG, Labtech, Germany), with a wavelength correction set at 570 nm. A standard 
curve was generated using a four-parameter logistic (4-PL) curve-fit (Microsoft 
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Office Excel) for each set of samples assayed. The values of the samples were 
assigned in relation to the standard curve.  
 
2.9 Statistical analysis 
The statistical significances of the results were analysed by a one-way analysis of 
variance (ANOVA), and Bonferroni post-hoc test. P values < 0.05 were considered to 
be statistically significant. 
 
3. Results 
3.1 Cytotoxic effects of P. gingivalis 
Initially, the possible cytotoxic effects of P. gingivalis culture supernatants on 
Monomac-6 cells were investigated. Bacterial protein concentrations ≤ 6.25 µg/ml did 
not elicit cytotoxicity after 24 h, since the levels of extracellularly released LDH in 
the challenged groups were not significantly different compared to the control (data 
not shown). Subsequently, sub-toxic P. gingivalis protein concentrations up-to 6.25 
µg/ml were selected for further experimentation.  
 
3.2 Effect of P. gingivalis on IL-1β and IL-18 mRNA expression 
The effect of P. gingivalis on IL-1β and IL-18 mRNA expression was next evaluated 
by quantitative real-time PCR. The cells were challenged with ascending protein 
concentrations of P. gingivalis culture supernatants for 6 h. Both IL-1β and IL-18 
mRNA levels were significantly increased in a dose-dependent manner (Fig. 1). 
Compared to the control, challenge with the highest P. gingivalis protein 
concentration (6.25 µg/ml) caused 11.8-fold and 32.0-fold increase in IL-1β and IL-18 
mRNA expression, respectively. 
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The effect of P. gingivalis on IL-1β and IL-18 mRNA expression over time 
was next investigated. P. gingivalis challenge (6.25 µg/ml) resulted in a time-
dependent enhancement of IL-1β mRNA expression between 2 h and 4 h, reaching 
maximal levels within 6 h, and then decreasing to control levels at 24 h (Fig. 2A). 
Similar P. gingivalis concentration also caused up-regulation of IL-18 mRNA 
expression, albeit in a more delayed manner, initiating between 4 h and 6 h. 
Nevertheless, in contrast to IL-1β, IL-18 mRNA expression did not decrease over 24 
h of challenge (Fig. 2B). 
 
3.3 Involvement of P. gingivalis virulence factors on IL-1β and IL-18 expression 
The next step was to identify the nature of P. gingivalis virulence factor(s) involved in 
the up-regulations of IL-1β and IL-18 mRNA expression. To determine the role of P. 
gingivalis proteins, or its cysteine proteases in particular, P. gingivalis culture 
supernatants were heat-inactivated, or TLCK-treated, respectively. Their effects on 
Monomac-6 cells were compared to those of the un-treated supernatants after 6 h of 
challenge. Both treatments resulted in significant reduction of IL-1β mRNA 
expression (p<0.001) by approximately 50 % (Fig. 3A). However, neither TLCK-
treatment, nor heat-inactivation affected the capacity of P. gingivalis to induce the up-
regulation of IL-18 mRNA expression (Fig. 3B). 
The effect of purified P. gingivalis LPS alone on the mRNA expression of 
these cytokines was further investigated after 6 h of challenge. It was found that 
concentration of 1000 ng/ml LPS significantly enhanced both IL-1β and IL-18 mRNA 
expression by the cells (Fig. 4). 
 
3.4 Effect of P. gingivalis on IL-1β and IL-18 protein secretion 
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The levels of secreted IL-1β and IL-18 in response to P. gingivalis were also 
investigated. After 6 h of challenge, P. gingivalis culture supernatants caused a 
concentration-dependent enhancement of IL-1β secretion by the cells (Fig. 5A). 
Nevertheless, when IL-18 secretion levels were investigated, these were undetectable 
under the present experimental conditions, with either IL-18 ELISA kit used (data not 
shown). Heat-inactivation or TLCK-treatment did not abolish the capacity of P. 
gingivalis culture supernatants (6.25 µg/ml) to stimulate IL-1β secretion, and purified 
P. gingivalis LPS alone (1000 ng/ml) was able to induce IL-1β secretion (Fig. 5B). 
 
4. Discussion 
This study demonstrated that P. gingivalis culture supernatants differentially regulate 
IL-18 and IL-1β gene expression in human monocytic cells. The data suggests that a 
heat-stable, non-proteolytic factor present in the culture supernatant, potentially its 
LPS, is mainly responsible for the induction of IL-18, but this is only partially 
responsible for the induction of IL-1β mRNA expression. However, only IL-1β 
appears to be secreted in response to P. gingivalis challenge, whereas IL-18 secretion 
was not detected under any of the studied conditions. 
Human Monomac-6 cells express very low levels of either cytokine. After P. 
gingivalis challenge, IL-1β expression was inducible between 2 h and 4 h, whereas 
IL-18 expression between 4 h and 6 h. Despite this delayed response, IL-18 
expression maintained persistent even after 24 h of challenge. On the contrary, IL-1β 
expression was down-regulated to control levels between 6 h and 24 h. Therefore the 
expression of IL-1β is earlier and transient, whereas that of IL-18 is more delayed and 
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persistent. These kinetics data denote that, despite being members of the same family, 
these two cytokines may have different roles, or act at different stages, in the 
establishment of periodontal inflammation in response to P. gingivalis challenge. The 
regulation of IL-1β mRNA expression in response to periodontal pathogens, including 
P. gingivalis, has been extensively studied [10, 35-37], and the present results are 
consistent with previous findings. The early and transient trend of IL-1β mRNA 
expression induction is in direct agreement with earlier findings in human monocytes 
challenged by E. coli and P. gingivalis LPS. It was concluded that IL-1β mRNA 
expression is short-lived and the time-course of the induction not dependent on the 
nature of bacterial challenge [36].  Although there is no data regarding IL-18 mRNA 
expression regulation by P. gingivalis, a recent study has reported that this is up-
regulated in Salmonella-challenged primary human monocytes [38]. In the present 
study, IL-18 protein secretion was not detected, as opposed to IL-1β. This could 
reflect the lower mRNA expression levels of IL-18, compared to IL-1β. This may be 
in line with recent findings demonstrating the lack of induction of IL-18 mRNA 
expression and protein secretion in fibroblasts by P. gingivalis LPS [30]. Since IL-1β 
precedes IL-18 induction, it could be anticipated that the former mediates the latter. 
Nevertheless, IL-18 mRNA expression level maintains steadily expressed over 24h, 
whereas that of IL-1β resumes control levels, making this possibility less likely. 
The involvement of P. gingivalis virulence factors, present in the culture 
supernatants, in the regulation of IL-1β and IL-18 expressions was further 
investigated. A number of potential virulence factors are expressed by P. gingivalis, 
the most well established being its LPS and its Arg-X and Lys-X gingipains, which 
are found in large quantities in the bacterial culture supernatants [9, 39]. A classical 
approach employed to investigate if the nature of the responsible virulence factor is 
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proteinaceous, is the heat-inactivation of the bacterial supernatants, which leaves 
intact the LPS. The involvement of cysteine proteinases was further investigated, by 
chemically blocking their activity with TLCK in the culture supernatants. 
Interestingly, neither TLCK-, nor heat-treatment affected the up-regulation of IL-18 
mRNA by P. gingivalis culture supernatants suggesting that the observed induction 
largely accounts for a non-proteinaceous and non-proteolytic virulence factor. On the 
contrary, both treatments reduced the capacity of P. gingivalis culture supernatants to 
stimulate IL-1β mRNA expression, indicating that the gingipains are partly involved 
in this process. However, on the protein secretion level, heat- and TLCK-treatment 
failed to reduce IL-1β secretion. The reason for this discrepancy between the 
regulation of IL-1β mRNA expression and protein secretion is unclear. A potential 
explanation could be that, despite the reduced mRNA expression, compensatory post-
transcriptional regulatory mechanisms may be in place, to stimulate IL-1β secretion at 
levels comparable to the untreated P. gingivalis culture supernatants.  
Since both cytokines appear to be regulated, either totally or in part, by a heat-
stable and non-proteolytic component, the main putative candidate was anticipated to 
be the LPS. To this extent, purified P. gingivalis LPS alone was sufficient to up-
regulate both IL-1β and IL-18 mRNA expression, but only IL-1β secretion in 
Monomac-6 cells. These findings may be in agreement with previous studies 
demonstrating that P. gingivalis LPS stimulates IL-1β secretion in human monocytic 
and epithelial cells, and fibroblasts [29-31, 33, 36], although IL-18 is shown to be 
produced by differentiated THP-1 monocytic cells [29] and epithelial cells [31].  
In conclusion, the present study demonstrated that the gene expression of IL-
1β and IL-18 can be differentially regulated in monocytic cells by P. gingivalis 
culture supernatants despite being members of the same cytokine superfamily. IL-1β 
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expression is induced early but transiently, whereas IL-18 induction is more delayed 
but its subsequent expression is maintained steady over time. Importantly, these 
regulations are attributed to different P. gingivalis virulence factors for each of the 
two cytokines. By inference, inhibition of gingipain activity indicates that these 
proteases are partly involved in IL-1β induction by P. gingivalis culture supernatants, 
whereas LPS may account for the remainder of the induction. On the contrary, only 
LPS appears to be responsible for the induction of IL-18 expression. This denotes that 
members of the IL-1 cytokine family may contribute in the complex processes of 
periodontal disease via different pathogenic mechanisms. In the case of the more 
recently identified IL-18, although its involvement in the pathogenesis of periodontitis 
is not yet clear, evidence suggests that it is present at higher levels in the disease [26, 
28, 40].  
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Figure Legends 
 
Figure 1 
Concentration-dependent regulation of IL-1β (A) and IL-18 (B) gene expression by P. 
gingivalis. Monomac-6 cell cultures were challenged with ascending protein 
concentrations of P. gingivalis culture supernatant for 6 h. The mRNA expression 
levels were measured by quantitative real-time PCR analysis, and normalized against 
the expression levels of GAPDH and UBC (internal controls). Bars represent mean 
values ± SEM from three independent experiments. Asterisk (*) indicates statistically 
significant difference from the control group. 
 
Figure 2 
Time-dependent regulation of IL-1β (A) and IL-18 (B) gene expression by P. 
gingivalis. Monomac-6 cell cultures were challenged with 6.25 µg/ml of P. gingivalis 
culture supernatant protein, up to 24 h. The mRNA expression levels were measured 
by quantitative real-time PCR analysis, and normalized against the expression levels 
of GAPDH and UBC (internal controls). Bars represent mean values ± SEM from 
three independent experiments. Asterisk (*) indicates statistically significant 
difference from the control group. 
 
Figure 3 
Effect of heat-inactivation and TLCK-treatment of P. gingivalis on the regulation of 
IL-1β (A) and IL-18 (B) gene expression. Monomac-6 cultures were challenged for 6 
h with 6.25 µg/ml of P. gingivalis culture supernatants, which were untreated, or heat-
inactivated, or TLCK-treated. The mRNA expression levels were measured by 
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quantitative real-time PCR analysis, and normalized against the expression levels of 
GAPDH and UBC (internal controls). Bars represent mean values ± SEM from three 
independent experiments. Asterisk (*) indicates statistically significant difference 
from the un-treated P. gingivalis group. 
 
Figure 4 
Effect of purified P. gingivalis LPS on the regulation of IL-1β (A) and IL-18 (B) gene 
expression. Monomac-6 cultures were challenged for 6 h with ascending 
concentrations of P. gingivalis LPS, up-to 1000 ng/ml. The mRNA expression levels 
were measured by quantitative real-time PCR analysis, and normalized against the 
expression levels of GAPDH and UBC (internal controls). Bars represent mean values 
± SEM from three independent experiments. Asterisk (*) indicates statistically 
significant difference from the control group. 
 
Figure 5 
Effect of P. gingivalis on the regulation of IL-1β secretion. Monomac-6 cultures were 
challenged for 6 h with ascending concentrations of P. gingivalis culture supernatants 
(A), or with heat-inactivated and TLCK-treated P. gingivalis culture supernatants 
(6.25 µg/ml), and purified P. gingivalis LPS alone (1000 ng/ml) (B). The secreted 
protein levels were measured by a commercially available ELISA kit. Bars represent 
mean values ± SEM from three independent experiments, expressed in pg/ml. 
Asterisk (*) indicates statistically significant difference from the control group (A), or 
from the untreated P. gingivalis group (B). 
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